A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2.

Wagstaff KM, Stein MS, Herschtal A, Rajter JJ, Rajter JC, Sallaberger M, Smileski A, Kanagalingam A, Jans DA

DOI: 10.3390/pharmaceutics17091205
Published: 2025 Sep 16
Container: Pharmaceutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics17091205,
  title = {A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2.},
  author = {Wagstaff KM and Stein MS and Herschtal A and Rajter JJ and Rajter JC and Sallaberger M and Smileski A and Kanagalingam A and Jans DA},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics17091205},
  url = {https://doi.org/10.3390/pharmaceutics17091205}
}

RIS

TY  - JOUR
TI  - A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2.
AU  - Wagstaff KM
AU  - Stein MS
AU  - Herschtal A
AU  - Rajter JJ
AU  - Rajter JC
AU  - Sallaberger M
AU  - Smileski A
AU  - Kanagalingam A
AU  - Jans DA
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics17091205
UR  - https://doi.org/10.3390/pharmaceutics17091205
ER  -

APA

KM, W., MS, S., A, H., JJ, R., JC, R., M, S., A, S., A, K., & DA, J. (2025). A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17091205

Source records

pubmed · retrieved 2026-09-26T05:38:53.969Z